Professor Stefan Pfister talks to ecancer about identifying prognostic biomarkers and next generation genomic sequencing at the European Forum on Oncology in Berlin, May 2012.

Working within the German Consortium for Translational Cancer Research, Prof Pfister explains their goals of increasing translational oncology in research and in the clinic. In the future, they hope to exploit sequencing technology in diagnostics so tumour and blood sequencing can take place for each patient.